留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

中国结直肠外科的未来发展之路

姚宏伟 张忠涛

姚宏伟, 张忠涛. 中国结直肠外科的未来发展之路[J]. 协和医学杂志, 2017, 8(2-3): 90-94. doi: 10.3969/j.issn.1674-9081.2017.03.002
引用本文: 姚宏伟, 张忠涛. 中国结直肠外科的未来发展之路[J]. 协和医学杂志, 2017, 8(2-3): 90-94. doi: 10.3969/j.issn.1674-9081.2017.03.002
Hong-wei YAO, Zhong-tao ZHANG. Perspectives of the Future Development of Colorectal Surgery in China[J]. Medical Journal of Peking Union Medical College Hospital, 2017, 8(2-3): 90-94. doi: 10.3969/j.issn.1674-9081.2017.03.002
Citation: Hong-wei YAO, Zhong-tao ZHANG. Perspectives of the Future Development of Colorectal Surgery in China[J]. Medical Journal of Peking Union Medical College Hospital, 2017, 8(2-3): 90-94. doi: 10.3969/j.issn.1674-9081.2017.03.002

中国结直肠外科的未来发展之路

doi: 10.3969/j.issn.1674-9081.2017.03.002
详细信息
    通讯作者:

    张忠涛  电话:010-63138768, E-mail: zhangzht@medmail.com.cn

  • 中图分类号: R656.9;R657.1

Perspectives of the Future Development of Colorectal Surgery in China

More Information
  • 摘要:

    我国结直肠外科手术技术发展迅猛, 但在专科化建设、诊疗规范化、临床研究的开展等方面仍落后于西方发达国家。因此, 我国结直肠外科未来应重点加强专科化建设, 提高结直肠疾病诊断和治疗的规范化程度, 推广结直肠外科手术的标准化和微创化; 更为重要的是, 应在全国性学术机构的组织下, 开展基于中国结直肠疾病患者的外科相关临床研究, 并获得高级别"循证医学"证据, 形成中国结直肠疾病的外科治疗相关指南, 用于指导我国结直肠疾病诊疗的外科临床实践。中国结直肠外科的未来发展任重而道远。

  • [1] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016[J]. CA Cancer J Clin, 2016, 66:7-30. doi:  10.3322/caac.21332
    [2] Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66:115-132. doi:  10.3322/caac.21338
    [3] Edge SB, Byrd DR, Compton CC, et al. AJCC Cancer Staging Manual[M].7th ed.New York:Springer, 2010:143-164.
    [4] Amin MB, Greene FL, Edge S, et al. AJCC Cancer Staging Manual[M].8th ed. New York:Springer, 2016:252-274.
    [5] 刘荫华, 姚宏伟, 周斌, 等.美国肿瘤联合会结直肠癌分期系统(第8版)更新解读[J].中国实用外科杂志, 2017, 37:6-9. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgsywkzz201701003
    [6] Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery-the clue to pelvic recurrence?[J]. Br J Surg, 1982, 69:613-616. doi:  10.1002/bjs.1800691019
    [7] Hohenberger W, Weber K, Matzel K, et al. Standardized surgery for colonic cancer:complete mesocolic excision and central ligation-technical notes and outcome[J]. Colorectal Dis, 2009, 11:354-364. doi:  10.1111/j.1463-1318.2008.01735.x
    [8] Clinical Outcomes of Surgical Therapy Study Group. A comparison of laparoscopically assisted and open colectomy for colon cancer[J]. N Engl J Med, 2004, 350:2050-2059. doi:  10.1056/NEJMoa032651
    [9] Jayne DG, Guillou PJ, Thorpe H, et al. Randomized trial of laparoscopic-assisted resection of colorectal carcinoma:3-year results of the UK MRC CLASICC Trial Group[J]. J Clin Oncol, 2007, 25:3061-3068. doi:  10.1200/JCO.2006.09.7758
    [10] Buunen M, Veldkamp R, Hop WC, et al. Survival after laparoscopic surgery versus open surgery for colon cancer:long-term outcome of a randomised clinical trial[J]. Lancet Oncol, 2009, 10:44-52. doi:  10.1016/S1470-2045(08)70310-3
    [11] Bonjer HJ, Deijen CL, Abis GA, et al. A randomized trial of laparoscopic versus open surgery for rectal cancer[J]. N Engl J Med, 2015, 372:1324-1332. doi:  10.1056/NEJMoa1414882
    [12] Jeong SY, Park JW, Nam BH, et al. Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial):survival outcomes of an open-label, non-inferiority, randomised controlled trial[J]. Lancet Oncol, 2014, 15:767-774. doi:  10.1016/S1470-2045(14)70205-0
    [13] Fleshman J, Branda M, Sargent DJ, et al. Effect of laparoscopic-assisted resection vs open resection of stage Ⅱ or Ⅲ rectal cancer on pathologic outcomes:The ACOSOG Z6051 Randomized Clinical Trial[J]. JAMA, 2015, 314:1346-1355. doi:  10.1001/jama.2015.10529
    [14] Stevenson AR, Solomon MJ, Lumley JW, et al. Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer:The ALaCaRT Randomized Clinical Trial[J]. JAMA, 2015, 314:1356-1363. doi:  10.1001/jama.2015.12009
    [15] Whitehouse M. A policy framework for commissioning cancer services[J]. BMJ, 1995, 310:1425-1426. doi:  10.1136/bmj.310.6992.1425
    [16] 姚宏伟, 修典荣, 付卫, 等.多学科协作诊治团队模式治疗可切除的结直肠癌肝转移[J].中华外科杂志, 2012, 50:961-965. doi:  10.3760/cma.j.issn.0529-5815.2012.11.001
    [17] 中华医学会消化病学分会胃肠动力学组, 中华医学会外科学分会结直肠肛门外科学组.中国慢性便秘诊治指南(2013年, 武汉)[J].中华消化杂志, 2013, 33:291-297. doi:  10.3760/cma.j.issn.0254-1432.2013.05.002
    [18] Heald RJ. A new solution to some old problems:transanal TME[J]. Tech Coloproctol, 2013, 17:257-258. doi:  10.1007/s10151-013-0984-0
    [19] Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer[J]. Nature, 2012, 487:330-337. doi:  10.1038/nature11252
    [20] Guinney J, Dienstmann R, Wang X, et al. The consensus molecular subtypes of colorectal cancer[J]. Nat Med, 2015, 21:1350-1356. doi:  10.1038/nm.3967
    [21] Ye LC, Liu TS, Ren L, et al. Randomized controlled trial of cetuximab plus chemotherapy for patients with KRAS wild-type unresectable colorectal liver-limited metastases[J]. J Clin Oncol, 2013, 31:1931-1938. doi:  10.1200/JCO.2012.44.8308
    [22] Deng Y, Chi P, Lan P, et al. Modified FOLFOX6 with or without radiation versus fluorouracil and leucovorin with radiation in neoadjuvant treatment of locally advanced rectal cancer:initial results of the Chinese FOWARC multicenter, open-label, randomized three-arm Phase Ⅲ Trial[J]. J Clin Oncol, 2016, 34:3300-3307. doi:  10.1200/JCO.2016.66.6198
  • 加载中
计量
  • 文章访问数:  411
  • HTML全文浏览量:  40
  • PDF下载量:  17
  • 被引次数: 0
出版历程
  • 收稿日期:  2017-04-30
  • 刊出日期:  2020-10-30

目录

    /

    返回文章
    返回

    【温馨提醒】近日,《协和医学杂志》编辑部接到作者反映,有多名不法人员冒充期刊编辑发送见刊通知,鼓动作者添加微信,从而骗取版面费的行为。特提醒您,本刊与作者联系的方式均为邮件通知或电话,稿件进度通知邮箱为:mjpumch@126.com,编辑部电话为:010-69154261,请提高警惕,谨防上当受骗!如有任何疑问,请致电编辑部核实。谢谢!